独家丨对话王小川：我没觉得委屈

Core Insights - The company has undergone significant organizational changes, reducing its workforce from 450 to under 200 and simplifying its management structure from 3.6 levels to 2.4 levels, allowing for more direct communication with top executives [1][20]. - The CEO, Wang Xiaochuan, emphasizes a strategic pivot towards focusing solely on the medical field, moving away from other sectors like finance and entertainment, which he believes diluted the company's efforts [3][5]. - The company has sufficient cash flow, enabling it to pursue non-consensus projects, particularly in the medical domain, which Wang views as essential for long-term success [2][9]. Organizational Changes - The company has streamlined its operations by reducing the number of employees and management levels, which has led to a more focused approach on medical applications [1][20]. - The decision to downsize was not driven by financial pressure but rather a commitment to the company's vision and mission [9][30]. - Wang has taken a hands-on approach in hiring, personally interviewing new candidates to ensure alignment with the company's medical focus [10][12]. Strategic Focus - The company aims to concentrate on three main areas: technological breakthroughs in medical applications, supporting doctors, and enhancing patient care outside of hospital settings [19][20]. - The shift towards a medical-centric strategy is seen as a non-consensus move, which Wang believes is necessary for the company's growth and differentiation in the market [5][6]. - The company plans to develop a life model based on data collected during the process of "creating doctors," which is viewed as a crucial step towards its ultimate goal [34]. Industry Context - The current landscape shows a growing interest in AI applications within the medical field, with nearly half of the unicorns in the U.S. being related to healthcare [28]. - The CEO acknowledges the challenges of integrating AI medical models into hospitals, highlighting the need to start from outside the hospital environment [39]. - The company is positioned to leverage the increasing acceptance of AI in healthcare, particularly in the Chinese market, which may have more explosive growth potential compared to the U.S. [38].